1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Long Table Growth Corp., a blank check company, closed its initial public offering on June 5, 2026, selling 17,250,000 units at $10.00 each, including the full exercise of the underwriter's over-allotment option. The company placed $173,362,500 in a trust account, and the filing says these funds will not be released until a business combination is completed or, absent one within 18 months, returned to public shareholders.
IPO closed June 5, 2026: 17,250,000 units at $10.00 each, for gross proceeds of $172.5 million, including 2,250,000 over-allotment units.
Sponsor Long Table Growth Sponsor LLC bought 3,600,000 private placement warrants at $1.00 each, for $3.6 million.
$173,362,500 placed in trust, or $10.05 per public unit; absent a business combination within 18 months, the funds are returned to public shareholders.
Rich Riley, Benjamin Doramus and Amir Husain were appointed independent directors on June 3, 2026.
Xos, Inc. sold 1,090,910 shares of common stock at $5.50 per share in a registered direct offering, for approximately $6.0 million in gross proceeds before placement agent fees and offering expenses. The sale was completed on June 5, 2026, under an existing shelf registration, so it adds new shares outstanding and provides cash to the company.
Shares sold at $5.50 each, 1,090,910 shares, approximately $6.0 million gross proceeds
Agreements dated June 4, 2026; sale completed June 5, 2026
Roth Capital Partners acted as exclusive placement agent, with a cash fee of 6.5% of gross proceeds plus up to $75,000 in expenses
Brown & Brown entered into a Third Amended and Restated Credit Agreement on June 5, 2026, replacing its October 27, 2021 credit agreement. The revolving facility rises from $800 million to $1.25 billion with maturity extended to June 5, 2031, and two term loans of $250 million each were added, with $825 million outstanding across the facilities as of filing.
Revolving Credit Facility increased from $800 million to $1,250 million, maturing June 5, 2031
Term A-1 Loan Facility of $250 million matures June 5, 2029
Term A-2 Loan Facility of $250 million matures June 5, 2031
$825 million outstanding under the Facilities as of the filing date
Alphabet sold two series of mandatory convertible preferred stock through depositary shares, with the offerings closing on June 5, 2026. The preferred pays a 6.25% dividend and converts into Class A or Class C common stock around May 15, 2029, which could add new shares to the count, while dividends on common stock are restricted until accumulated preferred dividends are paid.
Series A and Series B each had 167.5 million depositary shares sold, plus up to 25 million additional shares per series under over-allotment options that underwriters exercised in full on June 3, 2026.
Each depositary share is a 1/20th interest in a preferred share with a $1,000 liquidation preference; dividends are 6.25% per year, payable quarterly from August 15, 2026 through May 15, 2029.
Preferred shares convert on or about May 15, 2029 into between 2.2520 and 2.8160 Class A shares (Series A) and between 2.2740 and 2.8420 Class C shares (Series B), subject to adjustments.
While preferred stock is outstanding, no common stock dividends or buybacks are allowed unless accumulated preferred dividends have been paid; capped call cap prices are $532.6704 (Series A) and $527.7974 (Series B).
AEVEX Corp. priced an offering of its Class A common stock at $27.00 per share on June 3, 2026, under a Form S-1 registration statement, and the shares were delivered on June 5, 2026. The company is selling 5,726,157 shares and selling stockholders are selling 2,273,843 shares, so the company's share count rises by the shares it sells, while the selling stockholders receive proceeds from the shares they sell. The filing does not state the proceeds the company will receive.
Offering price: $27.00 per share, set June 3, 2026.
Company sells 5,726,157 Class A shares; selling stockholders sell 2,273,843 shares.
Underwriters have a 30-day option to buy up to 858,923 additional company shares and 341,077 additional selling stockholder shares.
Underwriters: Goldman Sachs & Co. LLC, BofA Securities, Inc. and Jefferies LLC as representatives; offering closed June 5, 2026.
Sensus Healthcare entered a Loan Agreement dated June 2, 2026, with City National Bank of Florida for a revolving credit facility of up to $15,000,000, secured by all company assets and $2,230,000 in cash collateral. The filing states the facility replaces a prior facility from Fifth Third Bank, which has been terminated, and lists lender consent requirements for asset sales, new debt, liens and removal of key officers.
Maximum borrowings of $15,000,000; advances bear SOFR plus 3% per annum and mature June 5, 2027 unless extended by mutual agreement
Loan secured by $2,230,000 in cash collateral and a security interest in all company assets
Lender consent required for non-ordinary-course asset sales, additional debt, new liens, or removal of the CEO, President or CFO
Financial covenant requires a minimum debt service coverage ratio of 1.50
FMC completed a $1.2 billion private offering of 8.000% senior secured notes maturing June 1, 2031, with net proceeds estimated at about $1.185 billion. The company plans to use the proceeds to repurchase or redeem its 3.200% notes due October 1, 2026, repay credit agreement borrowings, and for general corporate purposes, so shareholders will see a larger secured debt load at a higher interest rate.
$1.2 billion aggregate principal of 8.000% senior secured notes due June 1, 2031, issued at 100% of principal
Estimated net proceeds of approximately $1.185 billion after discounts, commissions and offering expenses
Proceeds intended to fund repurchase or redemption of 3.200% senior notes due October 1, 2026, and repay borrowings under the credit agreement dated June 17, 2022
Notes are secured by first-priority liens on substantially all assets of U.S., Canadian and Swiss guarantor entities, plus equity interests of Singapore and Netherlands subsidiaries
Planet Labs PBC entered into an Equity Distribution Agreement on June 5, 2026, allowing it to sell up to $1.5 billion of Class A common stock through an at-the-market program, including forward sale arrangements with banks. The filing says the shares will be sold under a shelf registration on Form S-3, and sales will be made at the Company's direction and price parameters. Because new shares could dilute existing holders, the program matters to shareholders, though the filing does not state how much stock has been sold so far.
Company may also enter into forward sale agreements with Goldman Sachs Bank USA and Citibank, N.A., with settlement in shares or cash
Sales agents commission of up to 2% of gross sales price per share sold through them as agent
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.